RxDoctor Payments DataLook up a doctor →

Sara Jones

Adult Health · Knoxville, TNNPI 1003057167

Payments from drug & device makers

$7,838in general payments, 2019–2025

Across 387 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Johnson & Johnson$706
  • E.r. Squibb & Sons, L.L.C.$366
  • AstraZeneca$357
  • Sanofi$295
  • Bristol Myers Squibb$294
  • plus $5K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis54$1,067
Johnson & Johnson(2 entities)24$706
E.r. Squibb & Sons, L.L.C.20$366
AstraZeneca(2 entities)18$357
Sanofi14$295
Bristol Myers Squibb16$294
Amgen17$288
Pfizer16$285
Merck12$278
Astellas Pharma US Inc13$250
Genentech USA, Inc.14$249
Takeda Pharmaceuticals U.S.A., Inc.10$211
Incyte Corporation10$204
AbbVie9$198
Daiichi Sankyo Inc.9$189
Exelixis Inc.9$171
Bayer9$154
AVEO Pharmaceuticals, Inc.4$140
Rigel Pharmaceuticals, Inc.8$123
Eisai Inc.6$108
Regeneron Healthcare Solutions, Inc.5$107
Pharmacyclics LLC, An Abbvie Company7$105
Lilly USA, LLC5$98
Janssen Scientific Affairs, LLC1$90
GSK4$82
Taiho Oncology, Inc.4$80
Beone Medicines USA, Inc.3$74
Deciphera Pharmaceuticals Inc.4$73
Karyopharm Therapeutics Inc.3$66
Tersera Therapeutics LLC2$63
Myriad Genetic Laboratories, Inc.4$59
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$57
Mirati Therapeutics, Inc.2$56
Boehringer Ingelheim3$56
Ipsen Biopharmaceuticals, Inc3$51
Tempus AI, Inc2$50
Pharmacosmos Therapeutics Inc.3$46
Seagen Inc.2$44
Caris MPI, Inc.2$39
Acceleron Pharma, Inc.2$39
Cumberland Pharmaceuticals, Inc.2$38
Jazz Pharmaceuticals Inc.2$34
Array Biopharma Inc2$34
ADC Therapeutics America, Inc.2$34
Alnylam Pharmaceuticals Inc.2$33
Springworks Therapeutics, Inc.1$32
Kyowa Kirin, Inc.2$28
Servier Pharmaceuticals LLC1$26
Blueprint Medicines Corporation1$23
Macrogenics, Inc.1$23
Geron Corporation1$21
Acrotech Biopharma Inc.1$21
Sun Pharmaceutical Industries Inc.1$20
Agios Pharmaceuticals, Inc.1$20
EMD Serono, Inc.1$19
Sobi, Inc1$19
Iovance Biotherapeutics, Inc.1$19
TG Therapeutics, Inc.1$18
Gilead1$17
Beigene USA, Inc.1$17

How this compares

$7,838 in reported general payments places this provider in the 90th percentile of 352 adult health providers in Tennessee.

See all adult health providers in Tennessee →

Medicare billing

Part B allowed, 2024
$35,029
Medicare patients
114
Services billed
358

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Knoxville

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →